Distractor-induced blindness (DIB) is elicited in a temporal selection task based on rapid serial visual presentation: Following the onset of a central cue (color change of fixation), a target in a global stream has to be detected (orientation change of tilted bars). Distractors are occasional target-like events presented prior to the onset of the cue. Depending on the number of distractor episodes, a frontal ERP negativity (FN) is evoked, and the detection rate of the forthcoming target is reduced. Here, we provide a concise review of the DIBs' functional characteristics, and examine the relationship between FN activation on target processing and detectability. To this end, ERP responses collected in a set of participants (n=14) were analysed separately with respect to detection performance (hits vs. misses). A gradual increase in the amplitude of the FN with increasing number of distractor events was only observed for forthcoming misses, but not for hits. The FN activation can be linked to a target-related ERP component: The amplitude of a late centro-parietal positivity (LPC) was significantly diminished for misses. In sum, the data support the notion that the DIB reflects the controlled activation of a central inhibition system. Depending on its state of activation, conscious access to stimuli defined by distinctive visual features is restricted.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.concog.2015.02.002DOI Listing

Publication Analysis

Top Keywords

central inhibition
8
inhibition system
8
distractor-induced blindness
8
blindness dib
8
number distractor
8
state central
4
system predicts
4
predicts access
4
access visual
4
visual targets
4

Similar Publications

Pancreatic ductal adenocarcinoma (PDAC) driven by the mutation presents a formidable health challenge because of limited treatment options. MRTX1133 is a highly selective and first-in-class KRAS-G12D inhibitor under clinical development. Here, we report that the advanced glycosylation end product-specific receptor (AGER) plays a key role in mediating MRTX1133 resistance in PDAC cells.

View Article and Find Full Text PDF

Small Molecule Modulators of AMP-Activated Protein Kinase (AMPK) Activity and Their Potential in Cancer Therapy.

J Med Chem

January 2025

Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, 12850 East Montview Boulevard, Aurora, Colorado 80045, United States.

AMP-activated protein kinase (AMPK) is a central mediator of cellular metabolism and is activated in direct response to low ATP levels. Activated AMPK inhibits anabolic pathways and promotes catabolic activities that generate ATP through the phosphorylation of multiple target substrates. AMPK is a therapeutic target for activation in several chronic metabolic diseases, and there is increasing interest in targeting AMPK activity in cancer where it can act as a tumor suppressor or conversely it can support cancer cell survival.

View Article and Find Full Text PDF

Lyophyllum decastes is a type of edible and medicinal mushroom with high nutritional value. However, it can be infected by fungi during the fruiting process, which impairs the development of the industry. In this study, one pathogenic fungus was isolated from the diseased fruiting bodies of L.

View Article and Find Full Text PDF

Background: Acute kidney injury (AKI) is a well-known complication of critical illnesses, significantly affecting morbidity and the risk of death. Diuretics are widely used to ameliorate excess fluid accumulation and oliguria associated with AKI. Their popularity stems from their ability to reduce the energy demands of renal tubular cells by inhibiting transporters and flushing out intratubular casts.

View Article and Find Full Text PDF

Glioblastoma (GBM) is the most common malignant primary brain tumor, with a mean survival of less than 2 years. Unique brain structures and the microenvironment, including blood-brain barriers, put great challenges on clinical drug development. Sophoricoside (Sop), an isoflavone glycoside isolated from seeds of Sophora japonica L.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!